Subscriber Login   Users   Administrators
Integrated cloud-based solutions for clinical laboratories

Sample Page

The page below is a sample from the MediaLab course, Rh negative female with anti-D at delivery: A case study.

Learn about Compliance & CE courses available for clinical laboratories and individual medical technologists.

RhIg & Variants of D

As noted, policies for administering RhIg to mothers with a variant of D vary among countries and within some countries.

An Rh(D) red blood cell phenotype with a weak or variant expression of the D antigen occurs in 0.2% to 1% of whites and is slightly more common in African Americans. The phenotype is routinely called weak D, although several variants exist.

A simple model includes these D variants:

1. Weak D

Multiple weak D variants exist. Red cells have fewer D antigens/red cell (quantitative difference) and only minor variations in D antigen proteins.

Some, but not all, weak D phenotypes are detected by today's Rh typing sera and may be classified as Rh positive or Rh negative by routine testing but will be positive when a weak D test (IAT with anti-D) is done.

An extreme form of weak D is the Del phenotype, in which the D antigen is so weakly expressed that it may be demonstrated only by adsorption and elution of anti-D.

Weak D individuals do NOT produce anti-D and can be considered to be Rh positive for transfusion and RhIg purposes.

2. Partial D

Partial D variants have altered Rh(D) proteins that differ sufficiently from normal D antigens (qualitative difference) to allow anti-D production. Partial D red cells may react with some but not all anti-D typing reagents. There are many categories of partial D antigens (e.g., DIIIa, DVI, DAR), each with a unique genetic basis.

Some persons with partial D have weakly expressed D epitopes and are designated "partial weak D."

In practice, partial D and weak partial D can be considered similarly, i.e., ideally they should be transfused with Rh negative RBC and are candidates to receive perinatal Rh immune globulin depending on the policy in their location.

 

 

MediaLab, Inc.

http://www.MediaLabInc.net    |    (877) 776-8460 (tollfree)    |    sales@medialabinc.net